Your browser doesn't support javascript.
loading
Correction: ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation.
Khatri, Aaditya; Gu, Jing Jin; McKernan, Courtney M; Xu, Xia; Pendergast, Ann Marie.
Afiliação
  • Khatri A; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, USA.
  • Gu JJ; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, USA.
  • McKernan CM; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, USA.
  • Xu X; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, USA.
  • Pendergast AM; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, USA.
Oncotarget ; 10(57): 6045-6046, 2019 Oct 15.
Article em En | MEDLINE | ID: mdl-31666936
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2019 Tipo de documento: Article